224 related articles for article (PubMed ID: 32960068)
21. Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery.
Ross BP; Braddy AC; McGeary RP; Blanchfield JT; Prokai L; Toth I
Mol Pharm; 2004; 1(3):233-45. PubMed ID: 15981926
[TBL] [Abstract][Full Text] [Related]
22. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320
[TBL] [Abstract][Full Text] [Related]
23. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
24. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
25. Human intestinal fluid factors affecting intestinal drug permeation in vitro.
Riethorst D; Brouwers J; Motmans J; Augustijns P
Eur J Pharm Sci; 2018 Aug; 121():338-346. PubMed ID: 29902511
[TBL] [Abstract][Full Text] [Related]
26. Aggregation Behavior of Medium Chain Fatty Acids Studied by Coarse-Grained Molecular Dynamics Simulation.
Hossain MS; Berg S; Bergström CAS; Larsson P
AAPS PharmSciTech; 2019 Jan; 20(2):61. PubMed ID: 30627943
[TBL] [Abstract][Full Text] [Related]
27. Characterization of bile acid absorption across the unstirred water layer and brush border of the rat jejunum.
Wilson FA; Dietschy JM
J Clin Invest; 1972 Dec; 51(12):3015-25. PubMed ID: 4674396
[TBL] [Abstract][Full Text] [Related]
28. Estimation of effective intestinal membrane permeability considering bile micelle solubilisation.
Sugano K
Int J Pharm; 2009 Feb; 368(1-2):116-22. PubMed ID: 18992315
[TBL] [Abstract][Full Text] [Related]
29. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
30. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
31. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
[TBL] [Abstract][Full Text] [Related]
32. Physical and barrier changes in gastrointestinal mucus induced by the permeation enhancer sodium 8-[(2-hydroxybenzoyl)amino]octanoate (SNAC).
Mortensen JS; Bohr SS; Harloff-Helleberg S; Hatzakis NS; Saaby L; Nielsen HM
J Control Release; 2022 Dec; 352():163-178. PubMed ID: 36314534
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the Pharmacokinetics and Systemic Effects of a Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl)amino] Caprylate in Rats.
Chiang PC; Deshmukh G; Liu J; Nagapudi K; Chen JZ; Valle N; Li R; Plise EG; Durk MR
J Pharm Sci; 2020 Aug; 109(8):2629-2636. PubMed ID: 32360544
[TBL] [Abstract][Full Text] [Related]
34. Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers.
Lindmark T; Nikkilä T; Artursson P
J Pharmacol Exp Ther; 1995 Nov; 275(2):958-64. PubMed ID: 7473188
[TBL] [Abstract][Full Text] [Related]
35. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes.
Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S
J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937
[TBL] [Abstract][Full Text] [Related]
36. Effect of sodium caprate on the intestinal absorption of two modified antisense oligonucleotides in pigs.
Raoof AA; Ramtoola Z; McKenna B; Yu RZ; Hardee G; Geary RS
Eur J Pharm Sci; 2002 Nov; 17(3):131-8. PubMed ID: 12393140
[TBL] [Abstract][Full Text] [Related]
37. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
Li Y; Zhu C
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
[TBL] [Abstract][Full Text] [Related]
38. The novel formulation design of self-emulsifying drug delivery systems (SEDDS) type O/W microemulsion III: the permeation mechanism of a poorly water soluble drug entrapped O/W microemulsion in rat isolated intestinal membrane by the Ussing chamber method.
Araya H; Tomita M; Hayashi M
Drug Metab Pharmacokinet; 2006 Feb; 21(1):45-53. PubMed ID: 16547393
[TBL] [Abstract][Full Text] [Related]
39. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug.
Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R
J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915
[TBL] [Abstract][Full Text] [Related]
40. In-vitro and in-vivo studies of cefpirom using bile salts as absorption enhancers.
Mrestani Y; Bretschneider B; Härtl A; Neubert RH
J Pharm Pharmacol; 2003 Dec; 55(12):1601-6. PubMed ID: 14738584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]